Skip to content
Business Segments · Acquisitions and divestitures

Health Care — Acquisitions and divestitures

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ3 2026Apr 24, 2026

How to read this metric

An increase suggests active portfolio restructuring or expansion into new health categories, while a decrease indicates a focus on organic growth or a pause in M&A activity.

Detailed definition

This metric tracks the net impact of business combinations, asset purchases, and the sale of business units specifically...

Peer comparison

Comparable to 'Net M&A impact' or 'Divestiture/Acquisition revenue adjustments' reported by diversified consumer health and pharmaceutical peers.

Metric ID: pg_segment_health_care_acquisitions_and_divestitures

Historical Data

15 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Value$0$0$0$0$0$0$0$0$0$0$0$0$0$0$40M
Range$0$40M

Frequently Asked Questions

What is Procter & Gamble's health care — acquisitions and divestitures?
Procter & Gamble (PG) reported health care — acquisitions and divestitures of $40M in Q1 2026.
What does health care — acquisitions and divestitures mean?
The net financial impact of buying or selling businesses within the Health Care segment.